Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma
Cancers · 16.10.2023 · 15 (20) · 5003
DOI: 10.3390/cancers15205003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 16.10.2023. Verfasst von Małgorzata Chmielewska-Kassassir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Structural Biology, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Lodz, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre, Cracow, Poland, Medical University of Lodz, Lodz, Poland.
Abstract (Originalsprache)
Purpose
To determine the mechanism of EPE in downregulating TYMS in MPM cancer.
Methods
The TYMS mRNA expression with epithelial-to-mesenchymal transition biomarkers and nuclear factor SP1 was assessed using the GEO database in a data set of MPM patients (GSE51024). Invasive MPM cell lines were in vitro models for the investigation of TYMS expression after EPE treatment. The tyms promoter SP1 binding sequences were determined using Genomatix v 3.4 software Electrophoretic mobility shift and dual-luciferase reporter assays revealed specific SP1 motifs in the interaction of EPE and reference compounds. Chromatin immunoprecipitation and Re-ChIP were used for the co-occupancy study.
Results
In MPM patients, a positive correlation of overexpressed TYMS with mesenchymal TWIST1, FN1 and N-cadherin was observed. EPE and its major components, gallic and ellagic acid (GA and EA, respectively), downregulated TYMS in invasive MPM cells by interacting with particular SP1 motifs on the tyms promoter. The luciferase constructs confirmed the occupation of two SP1 regulatory regions critical for the promotion of TYMS expression. Both EPE and reference standards influenced SP1 translocation into the nucleus.
Conclusion
EPE components reduced TYMS expression by occupation of SP1 motifs on the tyms promoter and reversed the EMT phenotype of invasive MPM cells. Further in-depth analysis of the molecular docking of polyphenol compounds with SP1 regulatory motifs is required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Structural Biology, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Lodz, Poland.
- Department of Molecular Cell Mechanisms, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
- Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Lodz, Poland.
ORCID-Profile: Małgorzata Chmielewska-Kassassir, Katarzyna Sobierajska, Wojciech M Ciszewski, Jakub Kryczka, Andrzej Zieleniak, Lucyna A Wozniak
Förderung
- National Science Center
- National Science Centre, Cracow, Poland
- Medical University of Lodz, Lodz, Poland
Zitieren
APA
Chmielewska-Kassassir, M., Sobierajska, K., Ciszewski, W. M., Kryczka, J., Zieleniak, A., & Wozniak, L. A. (2023). Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma. Cancers, 15(20), 5003. https://doi.org/10.3390/cancers15205003
Vancouver
Chmielewska-Kassassir M, Sobierajska K, Ciszewski WM, Kryczka J, Zieleniak A, Wozniak LA. Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma. Cancers. 2023;15(20):5003. doi:10.3390/cancers15205003
BibTeX
@article{ChmielewskaKassassir2023,
author = {Chmielewska-Kassassir, Małgorzata and Sobierajska, Katarzyna and Ciszewski, Wojciech M and Kryczka, Jakub and Zieleniak, Andrzej and Wozniak, Lucyna A},
title = {Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma},
journal = {Cancers},
year = {2023},
volume = {15},
number = {20},
pages = {5003},
doi = {10.3390/cancers15205003}
}
EUVIMED